Rotenone-induced mitochondrial dysfunction model for neuropsychiatric disorder research

Overview

This research offers a cutting-edge model that uses low-dose rotenone to induce mitochondrial dysfunction, thereby replicating neuropsychiatric disorder characteristics in mice. The model is particularly focused on mimicking a bipolar disorder-like phenotype, facilitating studies of psychiatric, neurodevelopmental, and neurodegenerative disorders. This approach provides valuable insights into the mitochondrial mechanisms underlying these complex disorders and opens new avenues for therapeutic exploration.

Technical specifications

• Modeling approach: Utilizes low-dose rotenone to induce mitochondrial dysfunction in mice and human-derived neuronal cell lines.
• Applications: Designed for in vitro and in vivo studies to mimic bipolar disorder-like symptoms.
• Future validation plans: Includes comprehensive omics analyses (proteomics, metabolomics, lipidomics, microbiome) and assessments of mitochondrial respiration in both male and female mice.

Technology readiness level

The technology is currently at TRL 6, indicating that it has been demonstrated in a relevant environment and is moving towards more advanced validation stages.